http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005072771-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2c4eb93908d2c9e4e7db6503e420fbc4
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-202
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-202
filingDate 2005-01-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0cefadf17802463f8429bbd240a0810e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_39924820edec27d64954bcbcc5d95d5d
publicationDate 2005-08-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2005072771-A1
titleOfInvention Neuroprotective complex for treatment of cerebral ischemia and injury
abstract This invention provides a pharmaceutical composition comprising albumin and polyunsaturated fatty acid useful in treating cerebral ischemia and cerebral injury. The pharmaceutical composition is also useful as a porphylactic treatment during surgical procedures wherein the potential for ischemic tissue damage is present. Also included in the invention is a method for preparing the pharmaceutical composition, as well as methods for treatment.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2009012784-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2009012785-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2009012784-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2009012785-A3
priorityDate 2004-01-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003032674-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1279400-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5043328-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5053490-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226410164
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395300
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3144
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226410163
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID445580
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226409294
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5497182
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID91670
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226409293
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129783903
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127794012
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128571702
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID175542
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3035421

Total number of triples: 38.